Cargando…
Open treatment of dysplasia—other than PAO: does it have to be a PAO?
Hip dysplasia is a developmental disorder that results in anatomic abnormalities in which the acetabular coverage is insufficient. In the absence of severe degenerative changes, younger active patients with these symptomatic structural abnormalities are increasingly managed with joint-preserving ope...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467430/ https://www.ncbi.nlm.nih.gov/pubmed/28630734 http://dx.doi.org/10.1093/jhps/hnv028 |
_version_ | 1783243278655684608 |
---|---|
author | Shibata, Kotaro R. Matsuda, Shuichi Safran, Marc R. |
author_facet | Shibata, Kotaro R. Matsuda, Shuichi Safran, Marc R. |
author_sort | Shibata, Kotaro R. |
collection | PubMed |
description | Hip dysplasia is a developmental disorder that results in anatomic abnormalities in which the acetabular coverage is insufficient. In the absence of severe degenerative changes, younger active patients with these symptomatic structural abnormalities are increasingly managed with joint-preserving operations. Historically there have been numerous reconstructive pelvic osteotomies. In recent years, the Bernese periacetabular osteotomy (PAO) has become the preferred osteotomy by many surgeons. Even so, as our understanding of the hip advances and new diagnostic and treatment techniques are developed, we sought to put a focus on the long-term results of augmental osteotomies and pelvic osteotomies other than the PAO, to see if any of these surgeries still have a place in the current algorithm of treatment for the dysplastic hip. As the longevity of the treatment is the focal point for joint preservation surgeries for the dysplastic hip, these authors have searched databases for articles in the English literature that reported results of long-term follow-up with a minimum of 11-year survivorship after surgical treatment of developmental dysplasia of the hip. Reconstruction osteotomies for the dysplastic hip are intended to restore normal hip anatomy and biomechanics, improve symptoms and prevent degenerative changes, in this manuscript each procedure is independently assessed on the ability to achieve these important characteristics. |
format | Online Article Text |
id | pubmed-5467430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-54674302017-06-19 Open treatment of dysplasia—other than PAO: does it have to be a PAO? Shibata, Kotaro R. Matsuda, Shuichi Safran, Marc R. J Hip Preserv Surg Review Articles Hip dysplasia is a developmental disorder that results in anatomic abnormalities in which the acetabular coverage is insufficient. In the absence of severe degenerative changes, younger active patients with these symptomatic structural abnormalities are increasingly managed with joint-preserving operations. Historically there have been numerous reconstructive pelvic osteotomies. In recent years, the Bernese periacetabular osteotomy (PAO) has become the preferred osteotomy by many surgeons. Even so, as our understanding of the hip advances and new diagnostic and treatment techniques are developed, we sought to put a focus on the long-term results of augmental osteotomies and pelvic osteotomies other than the PAO, to see if any of these surgeries still have a place in the current algorithm of treatment for the dysplastic hip. As the longevity of the treatment is the focal point for joint preservation surgeries for the dysplastic hip, these authors have searched databases for articles in the English literature that reported results of long-term follow-up with a minimum of 11-year survivorship after surgical treatment of developmental dysplasia of the hip. Reconstruction osteotomies for the dysplastic hip are intended to restore normal hip anatomy and biomechanics, improve symptoms and prevent degenerative changes, in this manuscript each procedure is independently assessed on the ability to achieve these important characteristics. Oxford University Press 2015-05-13 /pmc/articles/PMC5467430/ /pubmed/28630734 http://dx.doi.org/10.1093/jhps/hnv028 Text en © The Author 2015. Published by Oxford University Press http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Articles Shibata, Kotaro R. Matsuda, Shuichi Safran, Marc R. Open treatment of dysplasia—other than PAO: does it have to be a PAO? |
title | Open treatment of dysplasia—other than PAO: does it have to be a PAO? |
title_full | Open treatment of dysplasia—other than PAO: does it have to be a PAO? |
title_fullStr | Open treatment of dysplasia—other than PAO: does it have to be a PAO? |
title_full_unstemmed | Open treatment of dysplasia—other than PAO: does it have to be a PAO? |
title_short | Open treatment of dysplasia—other than PAO: does it have to be a PAO? |
title_sort | open treatment of dysplasia—other than pao: does it have to be a pao? |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467430/ https://www.ncbi.nlm.nih.gov/pubmed/28630734 http://dx.doi.org/10.1093/jhps/hnv028 |
work_keys_str_mv | AT shibatakotaror opentreatmentofdysplasiaotherthanpaodoesithavetobeapao AT matsudashuichi opentreatmentofdysplasiaotherthanpaodoesithavetobeapao AT safranmarcr opentreatmentofdysplasiaotherthanpaodoesithavetobeapao |